Evaluation of Early Conversion to Everolimus From Cyclosporine in de Novo Renal Transplant Recipients

NCT00634920 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

204

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Function

Interventions

DRUG: everolimus
DRUG: cyclosporine A
DRUG: Enteric Coated Mycophenolate Sodium (EC-MPS)
DRUG: corticosteroids
DRUG: Basiliximab

Sponsor

Novartis Pharmaceuticals